IN RECTAL SPACING CONTROL MATTERS
SAFE. SYMMETRIC. STABLE.
CONTROL MATTERS
CONTROL
MATTERS
Barrigel gives you effective and proven control over the shape and placement of the implant.3* Physician-controlled coverage allows you to create space with consistency and confidence.1
Hear from
BARRIGEL PHYSICIANS
“Barrigel completely removes the element of uncertainty from rectal spacing. It allows me to carefully plan and adjust the placement of the gel and provide my patients with the best chance to eliminate rectal toxicity. It has already made a huge difference to my prostate cancer patients!”
“In my experience, Barrigel is safer due to the ability to control its location and alter its placement during the procedure. This allows us to have a more uniform result in tougher cases where another procedure could result in delay of care.”
“My practice began using Barrigel because it allows me to take the time necessary to create a symmetrical implant that allows for protection of the entire rectum. Whether my patient is receiving IMRT, SBRT, or brachytherapy, Barrigel allows me to protect healthy tissue from unwanted radiation exposure and reduce side effects.”
SAFETY MATTERS
for improved
outcomes
and
reduced risk
Barrigel is the only rectal spacer
with proven reduction of
acute grade 2+ GI toxicity
compared to control, leading to
fewer side effects.1
Throughout the
Barrigel Pivotal Trial, there were
zero Barrigel-related
adverse events.1
SYMMETRY
MATTERS
Sculpt consistent, even coverage for optimal protection. In the Barrigel Pivotal Trial, >95% of implants were centered on the midline.2
STABILITY
MATTERS
Barrigel maintains space
throughout the course of treatment.
Even as Barrigel gradually resorbs, the
space created remains stable, with
no implant migration.1
SAFETY MATTERS
CREATE SPACE CONSISTENTLY AND SAFELY ONLY WITH BARRIGEL
* Data from the Barrigel Pivotal Study analyzed using the same methodology as the Fischer-Valuck study.
REFERENCES:
- Mariados NF, Orio PF III, Schiffman Z et al. Hyaluronic acid spacer for hypofractionated prostate radiation therapy: A randomized clinical trial. JAMA Oncol. 2023: e1-e8.
- King M, Svatos M, Chell EW. Assessment of NASHA Spacer Symmetry For Prostate Radiation Therapy. [ABSTRACT] Presented at American Brachytherapy Society Annual Conference, June 19, 2022.
- Fischer-Valuck BW, Chundury A, Gay H, Bosch W, Michalski J. Hydrogel spacer distribution within the perirectal space in patients undergoing radiotherapy for prostate cancer: Impact of spacer symmetry on rectal dose reduction and the clinical consequences of hydrogel infiltration into the rectal wall. Pract Radiat Oncol. 2017;7(3):195-202.
